NCT00575042View on ClinicalTrials.gov

Use of Fenofibrate for Primary Biliary Cirrhosis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2010

Conditions
Primary Biliary Cirrhosis
Interventions
DRUG

Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)

160 mg per day for 1 year

Trial Locations (2)

32610

University of Florida, Gainesville

55905

Mayo Clinic, Rochester

All Listed Sponsors
collaborator

The PBCers Organization

OTHER

collaborator

Shionogi Inc.

INDUSTRY

lead

University of Florida

OTHER

NCT00575042 - Use of Fenofibrate for Primary Biliary Cirrhosis | Biotech Hunter | Biotech Hunter